Bruker Corporation has emerged as the winner of an auction for NanoString Technologies and its spatial biology assets after the company filed for Chapter 11 bankruptcy earlier this year. The ...

Bruker (NASDAQ:BRKR) will buy NanoString Technologies, a Seattle-based innovator in gene expression profiling and spatial transcriptomics for ~$392.6M in cash, and the assumption of certain ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The acquisition marks the close ...

PLEASANTON, Calif., May 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent litigation ...

Bruker Corp. shows no sign of slowing its buying binge, picking up Nanostring Technologies Inc. for $392.6 million in cash plus the assumption of certain liabilities in its seventh deal so far this ...

A company with roots in developing tools for translational research has raised $15.3 million to execute the first step of its pursuit of market share in diagnostics. When it was granted the CE Mark in ...

Bruker Corp. announced that it has entered into a definitive acquisition agreement with NanoString Technologies, headquartered in Seattle. Under the asset purchase agreement, Bruker expects to acquire ...

Brad Gray talked to the Puget Sound Business Journal about how honing in on cancer diagnostics has already started to pay dividends. Seattle biotech NanoString Technologies (Nasdaq: NSTG) is finding ...

A little more than two months ago, NanoString Technologies filed for bankruptcy – weary from having to pay $31 million to 10X Genomics after losing a patent infringement lawsuit. Today is a different ...

In an order posted to the site of the U.S. District Court for the District of Delaware, the court stated: “10x Genomics (TXG), Inc. and Prognosys Biosciences, Inc. sued NanoString Technologies, Inc.1 ...